Esperion Therapeutics
(NASDAQ:ESPR)
$6.45
00
Last update: 4:00PM
Day High/Low- - -
52 Week High/Low3.28 - 21.68
Open / Close- / -
Float / Outstanding44.4M / 63M
Vol / Avg.0.7K / 1.2M
Mkt Cap406.4M
P/E-
50d Avg. Price5.78
Div / Yield-
Payout Ratio-
EPS-0.93
Total Float44.4M

Esperion Therapeutics (NASDAQ:ESPR), Quotes and News Summary

Esperion Therapeutics (NASDAQ: ESPR)

Day High/Low- - -
52 Week High/Low3.28 - 21.68
Open / Close- / -
Float / Outstanding44.4M / 63M
Vol / Avg.0.7K / 1.2M
Mkt Cap406.4M
P/E-
50d Avg. Price5.78
Div / Yield-
Payout Ratio-
EPS-0.93
Total Float44.4M
load more
Sector: Health Care.Industry: Pharmaceuticals
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS-1.040-0.930 0.1100
REV15.390M18.836M3.446M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Esperion Therapeutics Questions & Answers

Q
How do I buy Esperion Therapeutics (ESPR) stock?
A

You can purchase shares of Esperion Therapeutics (NASDAQ: ESPR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Esperion Therapeutics's (ESPR) competitors?
Q
What is the target price for Esperion Therapeutics (ESPR) stock?
A

The latest price target for Esperion Therapeutics (NASDAQ: ESPR) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 3.00 expecting ESPR to fall to within 12 months (a possible -53.49% downside). 11 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Esperion Therapeutics (ESPR)?
A

The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $6.45 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Esperion Therapeutics (ESPR) pay a dividend?
A

There are no upcoming dividends for Esperion Therapeutics.

Q
When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?
A

Esperion Therapeutics’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is Esperion Therapeutics (ESPR) going to split?
A

There is no upcoming split for Esperion Therapeutics.

Q
What sector and industry does Esperion Therapeutics (ESPR) operate in?
A

Esperion Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.